(Q38025713)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22788832%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22788832%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22788832%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Alienor Ferroni

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22788832%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Sibel Ertek

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22788832%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

language of work or name

English

0 references

publication date

13 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22788832%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Safety

7 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22788832%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22788832%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22788832%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

753-766

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22788832%20AND%20SRC:MED&resulttype=core&format=json

Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Gender-specific haemodynamic and metabolic effects of a sequential training programme on overweight-obese hypertensives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia; a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Nutritional supplements and serum lipids: does anything work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Culinary plants and their potential impact on metabolic overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Time- and dose-dependent effect of psyllium on serum lipids in mild-to-moderate hypercholesterolemia: a meta-analysis of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Effect of combining psyllium fiber with simvastatin in lowering cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Konjac-Mannan and American ginsing: emerging alternative therapies for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Glucomannan minimizes the postprandial insulin surge: a potential adjuvant for hepatothermic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Effect of dietary supplementation with glucomannan on plasma total cholesterol and low density lipoprotein cholesterol in hypercholesterolemic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Traditional uses and potential health benefits of Amorphophallus konjac K. Koch ex N.E.Br

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Esophageal obstruction from a hygroscopic pharmacobezoar containing glucomannan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Stanol esters as a component of maximal dietary therapy in the National Cholesterol Education Program Adult Treatment Panel III report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Phytosterols/stanols lower cholesterol concentrations in familial hypercholesterolemic subjects: a systematic review with meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

The effect of adding plant sterols or stanols to statin therapy in hypercholesterolemic patients: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

The structure and function of Niemann-Pick C1-like 1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Primary hyperlipidemias in children: effect of plant sterol supplementation on plasma lipids and markers of cholesterol synthesis and absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Vascular effects of diet supplementation with plant sterols

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Controversial role of plant sterol esters in the management of hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Differential effects on inhibition of cholesterol absorption by plant stanol and plant sterol esters in apoE-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

The effect of a very high daily plant stanol ester intake on serum lipids, carotenoids, and fat-soluble vitamins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Influence of consumption of probiotics on the plasma lipid profile: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

The gut microbiota ecology: a new opportunity for the treatment of metabolic diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Antihyperlipidaemic effect of a Monascus purpureus brand dietary supplement on a large sample of subjects at low risk for cardiovascular disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

A pilot study of the safety and efficacy of cholestin in treating HIV-related dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Efficacy and safety of Monascus purpureus Went rice in children and young adults with secondary hyperlipidemia: a preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Role of dietary supplements in lowering low-density lipoprotein cholesterol: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Acute hepatitis caused by a natural lipid-lowering product: when "alternative" medicine is no "alternative" at all

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Biologically active components and nutraceuticals in the Monascus-fermented rice: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Toxicological evaluation of red mould rice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

The role of red yeast rice for the physician

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Policosanols as nutraceuticals: fact or fiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Policosanol has no antioxidant activity in human low-density lipoprotein but increases excretion of bile acids in hamsters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

The treatment of hypercholesterolemic children: efficacy and safety of a combination of red yeast rice extract and policosanols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Garlic shows promise for improving some cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Interactions between herbal medicines and prescribed drugs: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Garlic flavonoids and organosulfur compounds: impact on the hepatic pharmacokinetics of saquinavir and darunavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Soy proteins and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Meta-analysis of the effects of soy protein intake on serum lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Therapeutic lifestyle changes and pharmaceutical care in the treatment of dyslipidemias in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Systematic review, meta-analysis and regression of randomised controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Effect of 3-month treatment of children and adolescents with familial and polygenic hypercholesterolaemia with a soya-substituted diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Hypertensive crisis associated with high dose soy isoflavone supplementation in a post-menopausal woman: a case report [ISRCTN98074661].

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Effect of soy milk on warfarin efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Drug interaction potential of soy extract and Panax ginseng

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Efficacy of berberine in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Cardiovascular and metabolic effects of Berberine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Activation of the aryl hydrocarbon receptor by berberine in HepG2 and H4IIE cells: Biphasic effect on CYP1A1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Guggul for hyperlipidemia: a review by the Natural Standard Research Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Antioxidant and anti-inflammatory properties of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Curcumin: the Indian solid gold

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Curcumin suppresses expression of low-density lipoprotein (LDL) receptor, leading to the inhibition of LDL-induced activation of hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Curcumin inhibits cholesterol uptake in Caco-2 cells by down-regulation of NPC1L1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Nutritional antioxidants and adaptive cell responses: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

A tea catechin, epigallocatechin-3-gallate, is a unique modulator of the farnesoid X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Green tea consumption and serum lipids and lipoproteins in a population of healthy workers in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Treating mixed hyperlipidemia and the atherogenic lipid phenotype for prevention of cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Expert opinion: omega-3 fatty acids and bleeding-cause for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Mercury, fish oils, and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Nutritional recommendations for preventing coronary heart disease in women: evidence concerning whole foods and supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

A quantitative risk-benefit analysis of changes in population fish consumption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Clinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827

Displacement of bilirubin from albumin by berberine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.705827